{"id":51104,"date":"2022-11-21T23:02:05","date_gmt":"2022-11-21T22:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/"},"modified":"2022-11-21T23:02:05","modified_gmt":"2022-11-21T22:02:05","slug":"sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/","title":{"rendered":"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat"},"content":{"rendered":"<div>\n<p>IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/TreatmentCenter?src=hash\" target=\"_blank\" rel=\"noopener\">#TreatmentCenter<\/a>&#8211;Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company\u2019s Chief Investment Officer; Peter Nyland, the company\u2019s Executive Vice President of Asset Management; Darrin Smith, the company\u2019s Executive Vice President of Investments; and Eliza Gozar, the company\u2019s Senior Vice President of Investments, will attend the eighth annual Treatment Center Investment and Valuation Retreat December 5-7, 2022, at the Fairmont Scottsdale Princess in Scottsdale, Arizona.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/5\/Sabra_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg\"><\/a><\/p>\n<p>\n<b>About Sabra<\/b>\n<\/p>\n<p>\nSabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a &#8220;REIT&#8221;) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nInvestor &amp; Media Inquiries:<br \/>\n<br \/>1-888-393-8248<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;l&#x74;&#x6f;&#58;&#105;n&#x76;&#x65;&#115;&#116;o&#x72;&#x69;&#110;qu&#x69;&#x72;&#105;e&#x73;&#x40;&#115;&#97;b&#x72;&#x61;&#104;&#101;a&#x6c;&#x74;&#104;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x6e;&#118;&#x65;&#115;&#x74;&#111;&#x72;&#105;&#x6e;&#113;&#x75;&#105;&#x72;&#105;&#x65;&#115;&#x40;&#115;&#x61;&#98;&#x72;&#97;&#x68;&#101;&#x61;&#108;&#x74;&#104;&#x2e;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;#TreatmentCenter&#8211;Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company\u2019s Chief Investment Officer; Peter Nyland, the company\u2019s Executive Vice President of Asset Management; Darrin Smith, the company\u2019s Executive Vice President of Investments; and Eliza Gozar, the company\u2019s Senior Vice President of Investments, will attend the eighth annual Treatment Center &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51104","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;#TreatmentCenter&#8211;Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company\u2019s Chief Investment Officer; Peter Nyland, the company\u2019s Executive Vice President of Asset Management; Darrin Smith, the company\u2019s Executive Vice President of Investments; and Eliza Gozar, the company\u2019s Senior Vice President of Investments, will attend the eighth annual Treatment Center ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-21T22:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat\",\"datePublished\":\"2022-11-21T22:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/\"},\"wordCount\":145,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005018\\\/en\\\/720475\\\/21\\\/Sabra_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/\",\"name\":\"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005018\\\/en\\\/720475\\\/21\\\/Sabra_Logo.jpg\",\"datePublished\":\"2022-11-21T22:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005018\\\/en\\\/720475\\\/21\\\/Sabra_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005018\\\/en\\\/720475\\\/21\\\/Sabra_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/","og_locale":"en_US","og_type":"article","og_title":"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat - Pharma Trend","og_description":"IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;#TreatmentCenter&#8211;Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Talya Nevo-Hacohen, the company\u2019s Chief Investment Officer; Peter Nyland, the company\u2019s Executive Vice President of Asset Management; Darrin Smith, the company\u2019s Executive Vice President of Investments; and Eliza Gozar, the company\u2019s Senior Vice President of Investments, will attend the eighth annual Treatment Center ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-21T22:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat","datePublished":"2022-11-21T22:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/"},"wordCount":145,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/","url":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/","name":"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg","datePublished":"2022-11-21T22:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221121005018\/en\/720475\/21\/Sabra_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sabra-health-care-reit-inc-to-attend-the-eighth-annual-treatment-center-investment-and-valuation-retreat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sabra Health Care REIT, Inc. to Attend the Eighth Annual Treatment Center Investment and Valuation Retreat"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51104"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51104\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}